Home > News > MIV Therapeutics Cited as Leading Technology Innovator
September 19th, 2006
MIV Therapeutics Cited as Leading Technology Innovator
Abstract:
"MIVT continues to gain recognition as a leader in the cardiovascular stent development industry," said Dr. Mark Landy, President of MIVT. "This Frost & Sullivan report is the latest validation for our hydroxyapatite-based nanotechnology and coatings, which we believe will someday be the product of choice for cardiologist around the world."
Source:
businesswire
Bookmark:
| Related News Press |
Nanomedicine
Tumor microenvironment dynamics: the regulatory influence of long non-coding RNAs April 25th, 2025
Next-generation drug delivery innovation! DGIST develops precision therapeutics using exosomes April 25th, 2025
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
Announcements
Enhancing power factor of p- and n-type single-walled carbon nanotubes April 25th, 2025
Tumor microenvironment dynamics: the regulatory influence of long non-coding RNAs April 25th, 2025
Ultrafast plasmon-enhanced magnetic bit switching at the nanoscale April 25th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||